Please, it would be much worse without us. Since we came on board numbers have increased, you are welcome.
-
Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
Janssen CNS
- Thread starter anonymous
- Start date
-
- Tags
- None
That is laughable. CV reps have no clue what they are doing. They are nice but they are arrogant, robotic and ruining relationships left and right in our psych offices.
agreed, the arrogance is the hardest to deal with. I’m actively looking for another job simply to get away from my partner and her manager.
You still feel things are “not toxic” anymore?! This is the most stressful and toxic environment I’ve ever worked in. Everyone is stressed and fighting. Everyone is pointing a finger at someone else for the lack of growth across all products. This once great division that cared about patients and customers has completely gone to s*#t in a matter of 6 months. All the CV people that are blaming and overworking their partners will be gone in a year. Now this is karma.
What a joke! LC is the worse manager I’ve worked with in 30 years.
Are you kidding? Do you work here? Toxic is an understatement.
Yes I do work here. It’s stressful but I wouldn’t call it toxic. Metrics, metrics and more metrics is our downfall. We are putting quantity over quality. Quantity does not produce sales results quantity produces the 7/75/75 they put out there.
Putting quantity over quality is the problem in all areas and is what is making things toxic! We have 2 reps per territory but really only 1 is doing the real work. Over stressing the people that have been here and are carrying all the new people vs bringing those people up to speed is completely toxic. Blaming someone else because of your lack of capabilities is completely toxic. leadership blaming everyone but themselves is toxic and causing undeserved stress.
I agree that "leadership" is blaming everyone but themselves, as usual. Nothing new in big pharma.
As a former CV rep, all I keep hearing about is how the original CNS/Neuroscience reps have these "great relationships" because they have worked in the territory for 10+ years. This is really laughable because most of the offices don't even know their names and their access is no better than the new reps. They're not fooling anyone but themselves and this is how the tension is created, and finger pointing starts. It's really a fear-based mentality in this division.
Personally, I'm glad that CV managers came over to help normalize this situation. After you have sold cardiovascular, these psych meds and disease state are a breeze to learn. However, I don't think the same could be said if these CNS reps tried to transfer to our division. They're work ethic and sales skills are blatantly inferior.
You must be JnJ lifer because if you think this is toxic you are sadly mistaken.
[QUOTE="leadership blaming everyone but themselves is toxic and causing undeserved stress.[/QUOTE]
Could not agree more...the pres, NSD’s, FSD’s, Marketing directors, Group Product Directors, Product Directors, etc, have completely underestimated the complexities of launching this new product and clearly do not completely appreciate or understand the direct relationship between our HCP’s providing a clinical service and their ability to be fairly compensated for their time. They seem to truly believe that our customer’s reluctance to use this product is some sort of “smoke screen” and need to be more clinically sold - and oh yeah, let’s educate our customers on how to submit a PA, code and the appeal process. I guess that’s kind of like our doctors/customers providing education to us on how to enter our calls into veeva. As a result, the blaming game has become predictable, intolerable, and at times comical. With this, there is no accountability with anyone, infighting amongst the teams, and the launch is failing. Leadership should hold themselves accountable and admit to their shortcomings- first and foremost!
Could not agree more...the pres, NSD’s, FSD’s, Marketing directors, Group Product Directors, Product Directors, etc, have completely underestimated the complexities of launching this new product and clearly do not completely appreciate or understand the direct relationship between our HCP’s providing a clinical service and their ability to be fairly compensated for their time. They seem to truly believe that our customer’s reluctance to use this product is some sort of “smoke screen” and need to be more clinically sold - and oh yeah, let’s educate our customers on how to submit a PA, code and the appeal process. I guess that’s kind of like our doctors/customers providing education to us on how to enter our calls into veeva. As a result, the blaming game has become predictable, intolerable, and at times comical. With this, there is no accountability with anyone, infighting amongst the teams, and the launch is failing. Leadership should hold themselves accountable and admit to their shortcomings- first and foremost!
Could not agree more...the pres, NSD’s, FSD’s, Marketing directors, Group Product Directors, Product Directors, etc, have completely underestimated the complexities of launching this new product and clearly do not completely appreciate or understand the direct relationship between our HCP’s providing a clinical service and their ability to be fairly compensated for their time. They seem to truly believe that our customer’s reluctance to use this product is some sort of “smoke screen” and need to be more clinically sold - and oh yeah, let’s educate our customers on how to submit a PA, code and the appeal process. I guess that’s kind of like our doctors/customers providing education to us on how to enter our calls into veeva. As a result, the blaming game has become predictable, intolerable, and at times comical. With this, there is no accountability with anyone, infighting amongst the teams, and the launch is failing. Leadership should hold themselves accountable and admit to their shortcomings- first and foremost![/QUOTE]
Quit your crying snowflake
Could not agree more...the pres, NSD’s, FSD’s, Marketing directors, Group Product Directors, Product Directors, etc, have completely underestimated the complexities of launching this new product and clearly do not completely appreciate or understand the direct relationship between our HCP’s providing a clinical service and their ability to be fairly compensated for their time. They seem to truly believe that our customer’s reluctance to use this product is some sort of “smoke screen” and need to be more clinically sold - and oh yeah, let’s educate our customers on how to submit a PA, code and the appeal process. I guess that’s kind of like our doctors/customers providing education to us on how to enter our calls into veeva. As a result, the blaming game has become predictable, intolerable, and at times comical. With this, there is no accountability with anyone, infighting amongst the teams, and the launch is failing. Leadership should hold themselves accountable and admit to their shortcomings- first and foremost![/QUOTE]
Very well said. I can tell you actually work at Janssen because this is exactly the way it is. The "quit your crying snowflake" person is a manager on the East Coast that is obsessed with what is said on CP. I have seen this manager posting on CP in the waiting room of a doctor's office, trolling the competition. What a complete loser.
There’s that arrogance everyone keeps talking about.
The former CVM reps are very pushy and their used car sales approach isn’t working it’s actually pissing doctors off.
Oh ok. So the legacy CNS reps have really crushed it with a whopping 5% market share for IS and less than 1% for IT with those superior selling skills? But hey, the docs are not pissed off though.
This statement shows you know less then nothing about the injectable market place